Xconomy National

Archives

by in
Entry Author Date Location
The Boston Life Sciences Newsmakers: Civitas, Blend, Forma, & More Erin Kutz 01/13/12 Boston
Civitas Charts Positive Data on Inhaled Parkinson’s Drug Arlene Weintraub 01/06/12 Boston
Infinity, Idera, Civitas, & More Boston-Area Life Sciences Headlines Erin Kutz 12/02/11 Boston
Rib-X, Skyhook, Michael J. Fox Foundation & More Boston-Area Deals News Erin Kutz 11/30/11 Boston
Alkermes Spinoff, Civitas, Gets Michael J. Fox Support for Inhalable Parkinson’s Drug Luke Timmerman 11/29/11 Boston
23andMe Identifies Possible Protective Gene Against Parkinson’s Disease Bruce V. Bigelow 10/25/11 San Diego
NIH Awards $2.1M grant for Parkinson’s Research at Wayne State University Sarah Schmid 09/26/11 Detroit
Neurologix Forges Ahead on Gene Therapy Treatment for Parkinson’s Arlene Weintraub 06/23/11 New York
NeuroHealing Repurposes Drugs, Resulting in Potential New Remedies For CNS Disorders Arlene Weintraub 06/02/11 Boston
23andMe Brings Down the Price of Consumer Genetic Tests, Builds Up Relations With Big Pharma Luke Timmerman 05/24/11 San Francisco
Prexa Pulls In $7M From Advent, Shire Erin Kutz 05/11/11 Boston
Acadia Raises $15M Bruce V. Bigelow 01/10/11 San Diego
Alkermes Finds New Home For Inhaled Drug-Delivery Tech with Civitas Spinout Ryan McBride 01/10/11 Boston
Boston Scientific Buys Intelect Ryan McBride 01/05/11 Boston
Biogen Idec Buys Drug Rights from Neurimmune for $32.5M Ryan McBride 12/21/10 Boston
Ceregene Adds $11.5M Luke Timmerman 11/11/10 San Diego
Exelixis Gets $60M from Bristol, Genentech Surpasses Original Herceptin, Synosia Pockets $30M, & More Bay Area Life Sciences News Luke Timmerman 10/15/10 San Francisco
Synosia Raises $30M, Strikes Deal With UCB Worth Up to $725M for Parkinson’s Drugs Luke Timmerman 10/12/10 San Francisco
Intrigue, Fraud Surround Death of Biotech Angel Investor, Neurocrine Biosciences Signs Two Big Deals, Regulus Therapeutics Signs Sanofi-Aventis Deal, & More San Diego Life Sciences News Bruce V. Bigelow 06/24/10 San Diego
Ceregene Gets $2.5M From Fox Foundation Bruce V. Bigelow 06/23/10 San Diego
San Diego’s Neurocrine Biosciences Scores Second Big Deal in Two Days Denise Gellene 06/18/10 San Diego
FoldRx Pharma Finds $29M, Plans to Seek Approval of First Drug in 2010 Ryan McBride 06/15/10 Boston
Avalon Raising New Fund, Althea Technologies Gets Altus Assets, Trancon Pharmaceuticals Nabs Financing, & More San Diego Life Sciences News Denise Gellene 05/06/10 San Diego
Link Medicine Ups Third Round to $45M, Taking Aim at Alzheimer’s and Parkinson’s Ryan McBride 05/04/10 Boston
Acadia Pharma Shares Crash After Lead Parkinson’s Drug Fails in Trial Ryan McBride 09/01/09 San Diego
Omeros Plans to Test Waters with First Washington IPO in Two Years, Sources Say Luke Timmerman 08/26/09 Seattle
Acadia Files Shelf Registration Denise Gellene 08/10/09 San Diego
Isis Prepares Novel Treatment for Lou Gehrig’s Disease, BrainCells Is Encouraged by New Drug for Depression, Inovio Raises $30M, & More San Diego Life Sciences News Bruce V. Bigelow 08/06/09 San Diego
No More Tears: Avanir Investors Await Trial Results on Emotional Outburst Drug Denise Gellene 07/23/09 San Diego
San Diego’s Acadia Awaits Parkinson’s Trial Results (and a Chance to Prove Naysayers Wrong) Denise Gellene 05/19/09 San Diego
Page 1 of 2 next page »
    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.